Freeman J L, Fetter R B, Park H, Schneider K C, Lichtenstein J L, Hughes J S, Bauman W A, Duncan C C, Freeman D H, Palmer G R
Department of Internal Medicine, University of Texas Medical Branch, Galveston 77555-0460, USA.
Med Care. 1995 Aug;33(8):806-27. doi: 10.1097/00005650-199508000-00006.
Diagnosis-related groups have been revised through more refined uses of secondary diagnoses. Under the refined diagnosis-related groups, patients are distinguished with respect to classes of secondary diagnoses that are disease- and procedure-specific. Each class represents a different level of utilization for a given principal diagnosis or surgical procedure. The refined system was evaluated with national data from the Medicare program. Estimates of hospital costs and utilization based on refined diagnosis-related groups were more precise than those based on unrefined diagnosis-related groups. This approach to diagnosis-related group refinement does not represent a radical departure from the current diagnosis-related group framework and does not require new data collection efforts. Moreover, a payment system based on the refined model is less affected by the ordering of the diagnoses than under the existing diagnosis-related group system. How the refined diagnosis-related group framework can accommodate future refinements at all levels of the classification scheme is also discussed.
通过更精细地使用次要诊断,诊断相关分组已得到修订。在精细化诊断相关分组下,患者根据特定疾病和特定手术的次要诊断类别进行区分。每个类别代表给定主要诊断或外科手术的不同利用水平。使用医疗保险计划的全国数据对该精细化系统进行了评估。基于精细化诊断相关分组的医院成本和利用率估计比基于未精细化诊断相关分组的估计更为精确。这种诊断相关分组精细化的方法并非彻底背离当前的诊断相关分组框架,也无需新的数据收集工作。此外,与现有诊断相关分组系统相比,基于精细化模型的支付系统受诊断排序的影响较小。本文还讨论了精细化诊断相关分组框架如何在分类方案的各个层面适应未来的细化。